Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the agency's Division of Dockets Management.
Submit written requests for copies of summaries of safety and effectiveness to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Nicole Wolanski, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Start Printed Page 1431Corporate Blvd., Rockville, MD 20850, 301-594-2186.End Further Info End Preamble Start Supplemental Information
In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule that revised 21 CFR 814.44(d) and 814.45(d) to discontinue individual publication of PMA approvals and denials in the Federal Register. Instead, the agency now posts this information on the Internet on FDA's home page at http://www.fda.gov. FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.
In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.
The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from July 1, 2005, through September 30, 2005. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.
|PMA No./Docket No.||Applicant||Trade name||Approval date|
|P040043/2005M-0320||W.L. Gore & Associates, Inc.||GORE TAG THORACIC ENDOPROSTHESIS||March 23, 2005|
|P030035(S3)/2005M-0289||St. Jude Medical||FRONTIER MODEL 5508L AND FRONTIER II MODEL 5586 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS (CRT-P) SUPPORTED ON THE MODEL 3510 PROGRAMMER PLATFORMS WITH THE MODEL 3307, V4.8M PROGRAMMER SOFTWARE||April 29, 2005|
|P040005/2005M-0387||DakoCytomation Denmark A/S||DAKOCYTOMATION HER2 FISH PHARMDX KIT||May 3, 2005|
|P030049/2005M-0270||Bayer Healthcare, LLC||ADVIA CENTAUR HBSAG READY PACK REAGENTS/CONFIRMATORY READY PACK REAGENTS/QUALITY CONTROL MATERIAL||May 26, 2005|
|P040037/2005M-0379||W.L. Gore & Associates, Inc.||VIABAHN ENDOPROSTHESIS||June 14, 2005|
|P040011/2005M-0388||DakoCytomation California, Inc.||DAKOCYTOMATION C-KIT PHARMDX||June 27, 2005|
|P950042(S3)/2005M-0284||Xillix Technologies Corp.||ONCO-LIFE ENDOSCOPIC LIGHT SOURCE AND VIDEO CAMERA||June 30, 2005|
|P970003(S50)/2005M-0283||Cyberonics, Inc.||VNS THERAPY SYSTEM||July 15, 2005|
|P030004/2005M-0328||Micro Therapeutics, Inc.||ONYX LIQUID EMBOLIC SYSTEM||July 21, 2005|
|H050001/2005M-0308||Boston Scientific Smart||WINGSPAN STENT SYSTEM WITH GATEWAY PTA BALLOON CATHETER||August 3, 2005|
|P030036/2005M-0380||Medtronic, Inc.||MEDTRONIC SELECTSECURE||August 3, 2005|
|P040021/2005M-0321||St. Jude Medical, Inc.||SJM BIOCOR VALVE/SJM BICOR SUPRA VALVE||August 5, 2005|
|P040039/2005M-0339||Orthometrix, Inc.||ORBASONE PAIN RELIEF SYSTEM||August 10, 2005|
|Start Printed Page 1432|
|P040044/2005M-0359||Access Closure, Inc.||MATRIX VSG SYSTEM MODEL MX-100||August 17, 2005|
|P930016(S21)/2005M-0382||Visx, Inc.||STAR S4 IR EXCIMER LASER SYSTEM WITH VARIABLE SPOT SCANNING (VSS)||August 30, 2005|
|P040038/2005M-0381||Abbott Vascular Devices||XACT CAROTID STENT SYSTEM||September 6, 2005|
|P930014(S15)/2005M-0378||Alcon Laboratories||ACRYSOF TORIC POSTERIOR CHAMBER INTRAOCULAR LENS||September 14, 2005|
II. Electronic Access
Persons with access to the Internet may obtain the documents at http://www.fda.gov/cdrh/pmapage.html.Start Signature
Dated: December 20, 2005.
Linda S. Kahan,
Deputy Director, Center for Devices and Radiological Health.
[FR Doc. E6-59 Filed 1-6-06; 8:45 am]
BILLING CODE 4160-01-S